Industry Research Reports

Home > Reports > Pharma & Healthcare > Global and United States New Drug for Alzheimer's Treatment Market Report & Forecast 2024-2030

Global and United States New Drug for Alzheimer's Treatment Market Report & Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-07-17

Pages: 102 Pages

Report ld: 3244479

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global New Drug for Alzheimer's Treatment revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).

In United States the New Drug for Alzheimer's Treatment revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States New Drug for Alzheimer's Treatment market, also covers the segmentation data of other regions in regional level and county level.

The global key players of New Drug for Alzheimer's Treatment include Biogen, Eisai, Eli Lilly, Neurimmune, Roche, AstraZeneca, Green Valley, Vivoryon, Simcere, Johnson and Johnson, etc. The global five biggest players hold a share of % in 2023.

New Drug for Alzheimer's Treatment market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global New Drug for Alzheimer's Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the New Drug for Alzheimer's Treatment market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

Market Segmentation

Report Metric
Details
Report Title
Global and United States New Drug for Alzheimer's Treatment Market Report & Forecast 2024-2030
Global New Drug for Alzheimer's Treatment Companies Covered
Biogen, Eisai, Eli Lilly, Neurimmune, Roche, AstraZeneca, Green Valley, Vivoryon, Simcere, Johnson and Johnson
Global New Drug for Alzheimer's Treatment Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global New Drug for Alzheimer's Treatment Market, Segment by Type
AChE Target

Aβ Target

BChE Target

Others
Global New Drug for Alzheimer's Treatment Market, Segment by Application
Preclinical Stage

Mild Cognitive Impairment Stage

Dementia Stage
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces New Drug for Alzheimer's Treatment definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of New Drug for Alzheimer's Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of New Drug for Alzheimer's Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, New Drug for Alzheimer's Treatment sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion

Table of Contents

 1 Study Coverage
    1.1 New Drug for Alzheimer's Treatment Product Introduction
    1.2 Global New Drug for Alzheimer's Treatment Outlook 2019 VS 2023 VS 2030
        1.2.1 Global New Drug for Alzheimer's Treatment Sales in US$ Million for the Year 2019-2030
        1.2.2 Global New Drug for Alzheimer's Treatment Sales in Volume for the Year 2019-2030
    1.3 United States New Drug for Alzheimer's Treatment Outlook 2019 VS 2023 VS 2030
        1.3.1 United States New Drug for Alzheimer's Treatment Sales in US$ Million for the Year 2019-2030
        1.3.2 United States New Drug for Alzheimer's Treatment Sales in Volume for the Year 2019-2030
    1.4 New Drug for Alzheimer's Treatment Market Size, United States VS Global, 2019 VS 2023 VS 2030
        1.4.1 The Market Share of United States New Drug for Alzheimer's Treatment in Global, 2019 VS 2023 VS 2030
        1.4.2 The Growth Rate of New Drug for Alzheimer's Treatment Market Size, United States VS Global, 2019 VS 2023 VS 2030
    1.5 New Drug for Alzheimer's Treatment Market Dynamics
        1.5.1 New Drug for Alzheimer's Treatment Industry Trends
        1.5.2 New Drug for Alzheimer's Treatment Market Drivers
        1.5.3 New Drug for Alzheimer's Treatment Market Challenges
        1.5.4 New Drug for Alzheimer's Treatment Market Restraints
    1.6 Assumptions and Limitations
    1.7 Study Objectives
    1.8 Years Considered

 2 New Drug for Alzheimer's Treatment by Type
    2.1 New Drug for Alzheimer's Treatment Market by Type
        2.1.1 AChE Target
        2.1.2 Aβ Target
        2.1.3 BChE Target
        2.1.4 Others
    2.2 Global New Drug for Alzheimer's Treatment Market Size by Type
        2.2.1 Global New Drug for Alzheimer's Treatment Sales in Value, by Type (2019, 2023 & 2030)
        2.2.2 Global New Drug for Alzheimer's Treatment Sales in Volume, by Type (2019, 2023 & 2030)
        2.2.3 Global New Drug for Alzheimer's Treatment Average Selling Price (ASP) by Type (2019, 2023 & 2030)
    2.3 United States New Drug for Alzheimer's Treatment Market Size by Type
        2.3.1 United States New Drug for Alzheimer's Treatment Sales in Value, by Type (2019, 2023 & 2030)
        2.3.2 United States New Drug for Alzheimer's Treatment Sales in Volume, by Type (2019, 2023 & 2030)
        2.3.3 United States New Drug for Alzheimer's Treatment Average Selling Price (ASP) by Type (2019, 2023 & 2030)

 3 New Drug for Alzheimer's Treatment by Application
    3.1 New Drug for Alzheimer's Treatment Market by Application
        3.1.1 Preclinical Stage
        3.1.2 Mild Cognitive Impairment Stage
        3.1.3 Dementia Stage
    3.2 Global New Drug for Alzheimer's Treatment Market Size by Application
        3.2.1 Global New Drug for Alzheimer's Treatment Sales in Value, by Application (2019, 2023 & 2030)
        3.2.2 Global New Drug for Alzheimer's Treatment Sales in Volume, by Application (2019, 2023 & 2030)
        3.2.3 Global New Drug for Alzheimer's Treatment Average Selling Price (ASP) by Application (2019, 2023 & 2030)
    3.3 United States New Drug for Alzheimer's Treatment Market Size by Application
        3.3.1 United States New Drug for Alzheimer's Treatment Sales in Value, by Application (2019, 2023 & 2030)
        3.3.2 United States New Drug for Alzheimer's Treatment Sales in Volume, by Application (2019, 2023 & 2030)
        3.3.3 United States New Drug for Alzheimer's Treatment Average Selling Price (ASP) by Application (2019, 2023 & 2030)

 4 Global New Drug for Alzheimer's Treatment Competitor Landscape by Company
    4.1 Global New Drug for Alzheimer's Treatment Market Size by Company
        4.1.1 Global Key Manufacturers of New Drug for Alzheimer's Treatment, Ranked by Revenue (2023)
        4.1.2 Global New Drug for Alzheimer's Treatment Revenue by Manufacturer (2019-2024)
        4.1.3 Global New Drug for Alzheimer's Treatment Sales by Manufacturer (2019-2024)
        4.1.4 Global New Drug for Alzheimer's Treatment Price by Manufacturer (2019-2024)
    4.2 Global New Drug for Alzheimer's Treatment Concentration Ratio (CR)
        4.2.1 New Drug for Alzheimer's Treatment Market Concentration Ratio (CR) (2019-2024)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of New Drug for Alzheimer's Treatment in 2023
        4.2.3 Global New Drug for Alzheimer's Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Key Manufacturers of New Drug for Alzheimer's Treatment, Manufacturing Base Distribution and Headquarters
    4.4 Global Key Manufacturers of New Drug for Alzheimer's Treatment, Product Offered and Application
    4.5 Global Key Manufacturers of New Drug for Alzheimer's Treatment, Date of Enter into This Industry
    4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.7 United States New Drug for Alzheimer's Treatment Market Size by Company
        4.7.1 Key Players of New Drug for Alzheimer's Treatment in United States, Ranked by Revenue (2023)
        4.7.2 United States New Drug for Alzheimer's Treatment Revenue by Players (2019-2024)
        4.7.3 United States New Drug for Alzheimer's Treatment Sales by Players (2019-2024)

 5 Global New Drug for Alzheimer's Treatment Market Size by Region
    5.1 Global New Drug for Alzheimer's Treatment Market Size by Region: 2019 VS 2023 VS 2030
    5.2 Global New Drug for Alzheimer's Treatment Market Size in Volume by Region (2019-2030)
        5.2.1 Global New Drug for Alzheimer's Treatment Sales in Volume by Region: 2019-2024
        5.2.2 Global New Drug for Alzheimer's Treatment Sales in Volume Forecast by Region (2025-2030)
    5.3 Global New Drug for Alzheimer's Treatment Market Size in Value by Region (2019-2030)
        5.3.1 Global New Drug for Alzheimer's Treatment Sales in Value by Region: 2019-2024
        5.3.2 Global New Drug for Alzheimer's Treatment Sales in Value by Region: 2025-2030

 6 Americas
    6.1 Americas New Drug for Alzheimer's Treatment Market Size YoY Growth 2019-2030
    6.2 Americas New Drug for Alzheimer's Treatment Sales in Volume, by Type (2019, 2023 & 2030)
    6.3 Americas New Drug for Alzheimer's Treatment Sales in Volume, by Application (2019, 2023 & 2030)
    6.4 Americas New Drug for Alzheimer's Treatment Market Facts & Figures by Country (2019, 2023 & 2030)
        6.4.1 Americas New Drug for Alzheimer's Treatment Sales in Value by Country (2019, 2023 & 2030)
        6.4.2 Americas New Drug for Alzheimer's Treatment Sales in Volume by Country (2019, 2023 & 2030)
        6.4.3 United States
        6.4.4 Canada
        6.4.5 Mexico
        6.4.6 Brazil

 7 EMEA
    7.1 EMEA New Drug for Alzheimer's Treatment Market Size YoY Growth 2019-2030
    7.2 EMEA New Drug for Alzheimer's Treatment Sales in Volume, by Type (2019, 2023 & 2030)
    7.3 EMEA New Drug for Alzheimer's Treatment Sales in Volume, by Application (2019, 2023 & 2030)
    7.4 EMEA New Drug for Alzheimer's Treatment Market Facts & Figures by Country (2019, 2023 & 2030)
        7.4.1 EMEA New Drug for Alzheimer's Treatment Sales in Value by Country (2019, 2023 & 2030)
        7.4.2 EMEA New Drug for Alzheimer's Treatment Sales in Volume by Country (2019, 2023 & 2030)
        7.4.3 Europe
        7.4.4 Middle East
        7.4.5 Africa

 8 China
    8.1 China New Drug for Alzheimer's Treatment Market Size YoY Growth 2019-2030
    8.2 China New Drug for Alzheimer's Treatment Sales in Volume, by Type (2019, 2023 & 2030)
    8.3 China New Drug for Alzheimer's Treatment Sales in Volume, by Application (2019, 2023 & 2030)

 9 APAC
    9.1 APAC New Drug for Alzheimer's Treatment Market Size YoY Growth 2019-2030
    9.2 APAC New Drug for Alzheimer's Treatment Sales in Volume, by Type (2019, 2023 & 2030)
    9.3 APAC New Drug for Alzheimer's Treatment Sales in Volume, by Application (2019, 2023 & 2030)
    9.4 APAC New Drug for Alzheimer's Treatment Market Facts & Figures by Country (2019, 2023 & 2030)
        9.4.1 APAC New Drug for Alzheimer's Treatment Sales in Value by Country (2019, 2023 & 2030)
        9.4.2 APAC New Drug for Alzheimer's Treatment Sales in Volume by Country (2019, 2023 & 2030)
        9.4.3 Japan
        9.4.4 South Korea
        9.4.5 China Taiwan
        9.4.6 Southeast Asia
        9.4.7 India

 10 Company Profiles
    10.1 Biogen
        10.1.1 Biogen Company Information
        10.1.2 Biogen Description and Business Overview
        10.1.3 Biogen New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        10.1.4 Biogen New Drug for Alzheimer's Treatment Products Offered
        10.1.5 Biogen Recent Development
    10.2 Eisai
        10.2.1 Eisai Company Information
        10.2.2 Eisai Description and Business Overview
        10.2.3 Eisai New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        10.2.4 Eisai New Drug for Alzheimer's Treatment Products Offered
        10.2.5 Eisai Recent Development
    10.3 Eli Lilly
        10.3.1 Eli Lilly Company Information
        10.3.2 Eli Lilly Description and Business Overview
        10.3.3 Eli Lilly New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        10.3.4 Eli Lilly New Drug for Alzheimer's Treatment Products Offered
        10.3.5 Eli Lilly Recent Development
    10.4 Neurimmune
        10.4.1 Neurimmune Company Information
        10.4.2 Neurimmune Description and Business Overview
        10.4.3 Neurimmune New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        10.4.4 Neurimmune New Drug for Alzheimer's Treatment Products Offered
        10.4.5 Neurimmune Recent Development
    10.5 Roche
        10.5.1 Roche Company Information
        10.5.2 Roche Description and Business Overview
        10.5.3 Roche New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        10.5.4 Roche New Drug for Alzheimer's Treatment Products Offered
        10.5.5 Roche Recent Development
    10.6 AstraZeneca
        10.6.1 AstraZeneca Company Information
        10.6.2 AstraZeneca Description and Business Overview
        10.6.3 AstraZeneca New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        10.6.4 AstraZeneca New Drug for Alzheimer's Treatment Products Offered
        10.6.5 AstraZeneca Recent Development
    10.7 Green Valley
        10.7.1 Green Valley Company Information
        10.7.2 Green Valley Description and Business Overview
        10.7.3 Green Valley New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        10.7.4 Green Valley New Drug for Alzheimer's Treatment Products Offered
        10.7.5 Green Valley Recent Development
    10.8 Vivoryon
        10.8.1 Vivoryon Company Information
        10.8.2 Vivoryon Description and Business Overview
        10.8.3 Vivoryon New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        10.8.4 Vivoryon New Drug for Alzheimer's Treatment Products Offered
        10.8.5 Vivoryon Recent Development
    10.9 Simcere
        10.9.1 Simcere Company Information
        10.9.2 Simcere Description and Business Overview
        10.9.3 Simcere New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        10.9.4 Simcere New Drug for Alzheimer's Treatment Products Offered
        10.9.5 Simcere Recent Development
    10.10 Johnson and Johnson
        10.10.1 Johnson and Johnson Company Information
        10.10.2 Johnson and Johnson Description and Business Overview
        10.10.3 Johnson and Johnson New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        10.10.4 Johnson and Johnson New Drug for Alzheimer's Treatment Products Offered
        10.10.5 Johnson and Johnson Recent Development

 11 Industry Chain and Sales Channels Analysis
    11.1 New Drug for Alzheimer's Treatment Industry Chain Analysis
    11.2 New Drug for Alzheimer's Treatment Key Raw Materials
        11.2.1 Key Raw Materials
        11.2.2 Raw Materials Key Suppliers
    11.3 New Drug for Alzheimer's Treatment Production Mode & Process
    11.4 New Drug for Alzheimer's Treatment Sales and Marketing
        11.4.1 New Drug for Alzheimer's Treatment Sales Channels
        11.4.2 New Drug for Alzheimer's Treatment Distributors
    11.5 New Drug for Alzheimer's Treatment Customers

 12 Research Findings and Conclusion

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. New Drug for Alzheimer's Treatment CAGR in Value, United States VS Global, 2019 VS 2023 VS 2030
 Table 2. New Drug for Alzheimer's Treatment Market Trends
 Table 3. New Drug for Alzheimer's Treatment Market Drivers
 Table 4. New Drug for Alzheimer's Treatment Market Challenges
 Table 5. New Drug for Alzheimer's Treatment Market Restraints
 Table 6. Global New Drug for Alzheimer's Treatment Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 7. United States New Drug for Alzheimer's Treatment Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 8. Global New Drug for Alzheimer's Treatment Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 9. United States New Drug for Alzheimer's Treatment Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 10. Global Key Manufacturers of New Drug for Alzheimer's Treatment, Ranked by Revenue (2023) & (US$ Million)
 Table 11. Global New Drug for Alzheimer's Treatment Revenue by Manufacturer, (US$ Million) & (2019-2024)
 Table 12. Global New Drug for Alzheimer's Treatment Revenue Share by Manufacturer, 2019-2024
 Table 13. Global New Drug for Alzheimer's Treatment Sales by Manufacturer, (K Dose), 2019-2024
 Table 14. Global New Drug for Alzheimer's Treatment Sales Share by Manufacturer, 2019-2024
 Table 15. Global New Drug for Alzheimer's Treatment Price by Manufacturer (2019-2024) & (US$/Dose)
 Table 16. Global New Drug for Alzheimer's Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 17. Global New Drug for Alzheimer's Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Drug for Alzheimer's Treatment as of 2023)
 Table 18. Global Key Manufacturers of New Drug for Alzheimer's Treatment, Manufacturing Base Distribution and Headquarters
 Table 19. Global Key Manufacturers of New Drug for Alzheimer's Treatment, Product Offered and Application
 Table 20. Global Key Manufacturers of New Drug for Alzheimer's Treatment, Date of Enter into This Industry
 Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 22. Key Players of New Drug for Alzheimer's Treatment in United States, Ranked by Revenue (2023) & (US$ million)
 Table 23. United States New Drug for Alzheimer's Treatment Revenue by Players, (US$ Million) & (2019-2024)
 Table 24. United States New Drug for Alzheimer's Treatment Revenue Share by Players, (2019-2024)
 Table 25. United States New Drug for Alzheimer's Treatment Sales by Players, (K Dose) & (2019-2024)
 Table 26. United States New Drug for Alzheimer's Treatment Sales Share by Players, (2019-2024)
 Table 27. Global New Drug for Alzheimer's Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 28. Global New Drug for Alzheimer's Treatment Sales in Volume by Region (2019-2024) & (K Dose)
 Table 29. Global New Drug for Alzheimer's Treatment Sales in Volume Forecast by Region (2025-2030) & (K Dose)
 Table 30. Global New Drug for Alzheimer's Treatment Sales in Value by Region (2019-2024) & (US$ Million)
 Table 31. Global New Drug for Alzheimer's Treatment Sales in Value Forecast by Region (2025-2030) & (US$ Million)
 Table 32. Americas New Drug for Alzheimer's Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. Americas New Drug for Alzheimer's Treatment Sales in Value by Country (2019-2024) & (US$ Million)
 Table 34. Americas New Drug for Alzheimer's Treatment Sales in Value by Country (2025-2030) & (US$ Million)
 Table 35. Americas New Drug for Alzheimer's Treatment Sales in Volume by Country (2019-2024) & (K Dose)
 Table 36. Americas New Drug for Alzheimer's Treatment Sales in Volume by Country (2025-2030) & (K Dose)
 Table 37. EMEA New Drug for Alzheimer's Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. EMEA New Drug for Alzheimer's Treatment Sales in Value by Country (2019-2024) & (US$ Million)
 Table 39. EMEA New Drug for Alzheimer's Treatment Sales in Value by Country (2025-2030) & (US$ Million)
 Table 40. EMEA New Drug for Alzheimer's Treatment Sales in Volume by Country (2019-2024) & (K Dose)
 Table 41. EMEA New Drug for Alzheimer's Treatment Sales in Volume by Country (2025-2030) & (K Dose)
 Table 42. APAC New Drug for Alzheimer's Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. APAC New Drug for Alzheimer's Treatment Sales in Value by Country (2019-2024) & (US$ Million)
 Table 44. APAC New Drug for Alzheimer's Treatment Sales in Value by Country (2025-2030) & (US$ Million)
 Table 45. APAC New Drug for Alzheimer's Treatment Sales in Volume by Country (2019-2024) & (K Dose)
 Table 46. APAC New Drug for Alzheimer's Treatment Sales in Volume by Country (2025-2030) & (K Dose)
 Table 47. Biogen Company Information
 Table 48. Biogen Description and Business Overview
 Table 49. Biogen New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 50. Biogen New Drug for Alzheimer's Treatment Product
 Table 51. Biogen Recent Development
 Table 52. Eisai Company Information
 Table 53. Eisai Description and Business Overview
 Table 54. Eisai New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 55. Eisai New Drug for Alzheimer's Treatment Product
 Table 56. Eisai Recent Development
 Table 57. Eli Lilly Company Information
 Table 58. Eli Lilly Description and Business Overview
 Table 59. Eli Lilly New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 60. Eli Lilly New Drug for Alzheimer's Treatment Product
 Table 61. Eli Lilly Recent Development
 Table 62. Neurimmune Company Information
 Table 63. Neurimmune Description and Business Overview
 Table 64. Neurimmune New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 65. Neurimmune New Drug for Alzheimer's Treatment Product
 Table 66. Neurimmune Recent Development
 Table 67. Roche Company Information
 Table 68. Roche Description and Business Overview
 Table 69. Roche New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 70. Roche New Drug for Alzheimer's Treatment Product
 Table 71. Roche Recent Development
 Table 72. AstraZeneca Company Information
 Table 73. AstraZeneca Description and Business Overview
 Table 74. AstraZeneca New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 75. AstraZeneca New Drug for Alzheimer's Treatment Product
 Table 76. AstraZeneca Recent Development
 Table 77. Green Valley Company Information
 Table 78. Green Valley Description and Business Overview
 Table 79. Green Valley New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 80. Green Valley New Drug for Alzheimer's Treatment Product
 Table 81. Green Valley Recent Development
 Table 82. Vivoryon Company Information
 Table 83. Vivoryon Description and Business Overview
 Table 84. Vivoryon New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 85. Vivoryon New Drug for Alzheimer's Treatment Product
 Table 86. Vivoryon Recent Development
 Table 87. Simcere Company Information
 Table 88. Simcere Description and Business Overview
 Table 89. Simcere New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 90. Simcere New Drug for Alzheimer's Treatment Product
 Table 91. Simcere Recent Development
 Table 92. Johnson and Johnson Company Information
 Table 93. Johnson and Johnson Description and Business Overview
 Table 94. Johnson and Johnson New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 95. Johnson and Johnson New Drug for Alzheimer's Treatment Product
 Table 96. Johnson and Johnson Recent Development
 Table 97. Key Raw Materials Lists
 Table 98. Raw Materials Key Suppliers Lists
 Table 99. New Drug for Alzheimer's Treatment Distributors List
 Table 100. New Drug for Alzheimer's Treatment Customers List
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources


List of Figures
 Figure 1. New Drug for Alzheimer's Treatment Product Picture
 Figure 2. Global New Drug for Alzheimer's Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 3. Global New Drug for Alzheimer's Treatment Market Size 2019-2030 (US$ Million)
 Figure 4. Global New Drug for Alzheimer's Treatment Sales 2019-2030 (K Dose)
 Figure 5. United States New Drug for Alzheimer's Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 6. United States New Drug for Alzheimer's Treatment Market Size 2019-2030 (US$ Million)
 Figure 7. United States New Drug for Alzheimer's Treatment Sales 2019-2030 (K Dose)
 Figure 8. United States New Drug for Alzheimer's Treatment Market Share in Global, in Value (US$ Million) 2019-2030
 Figure 9. United States New Drug for Alzheimer's Treatment Market Share in Global, in Volume (K Dose) 2019-2030
 Figure 10. New Drug for Alzheimer's Treatment Report Years Considered
 Figure 11. Product Picture of AChE Target
 Figure 12. Product Picture of Aβ Target
 Figure 13. Product Picture of BChE Target
 Figure 14. Product Picture of Others
 Figure 15. Global New Drug for Alzheimer's Treatment Market Share by Type in 2023 & 2030
 Figure 16. Global New Drug for Alzheimer's Treatment Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 17. Global New Drug for Alzheimer's Treatment Sales Market Share in Value by Type (2019-2030)
 Figure 18. Global New Drug for Alzheimer's Treatment Sales by Type (2019-2030) & (K Dose)
 Figure 19. Global New Drug for Alzheimer's Treatment Sales Market Share in Volume by Type (2019-2030)
 Figure 20. Global New Drug for Alzheimer's Treatment Price by Type (2019-2030) & (US$/Dose)
 Figure 21. United States New Drug for Alzheimer's Treatment Market Share by Type in 2023 & 2030
 Figure 22. United States New Drug for Alzheimer's Treatment Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 23. United States New Drug for Alzheimer's Treatment Sales Market Share in Value by Type (2019-2030)
 Figure 24. United States New Drug for Alzheimer's Treatment Sales by Type (2019-2030) & (K Dose)
 Figure 25. United States New Drug for Alzheimer's Treatment Sales Market Share in Volume by Type (2019-2030)
 Figure 26. United States New Drug for Alzheimer's Treatment Price by Type (2019-2030) & (US$/Dose)
 Figure 27. Product Picture of Preclinical Stage
 Figure 28. Product Picture of Mild Cognitive Impairment Stage
 Figure 29. Product Picture of Dementia Stage
 Figure 30. Global New Drug for Alzheimer's Treatment Market Share by Application in 2023 & 2030
 Figure 31. Global New Drug for Alzheimer's Treatment Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 32. Global New Drug for Alzheimer's Treatment Sales Market Share in Value by Application (2019-2030)
 Figure 33. Global New Drug for Alzheimer's Treatment Sales by Application (2019-2030) & (K Dose)
 Figure 34. Global New Drug for Alzheimer's Treatment Sales Market Share in Volume by Application (2019-2030)
 Figure 35. Global New Drug for Alzheimer's Treatment Price by Application (2019-2030) & (US$/Dose)
 Figure 36. United States New Drug for Alzheimer's Treatment Market Share by Application in 2023 & 2030
 Figure 37. United States New Drug for Alzheimer's Treatment Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 38. United States New Drug for Alzheimer's Treatment Sales Market Share in Value by Application (2019-2030)
 Figure 39. United States New Drug for Alzheimer's Treatment Sales by Application (2019-2030) & (K Dose)
 Figure 40. United States New Drug for Alzheimer's Treatment Sales Market Share in Volume by Application (2019-2030)
 Figure 41. United States New Drug for Alzheimer's Treatment Price by Application (2019-2030) & (US$/Dose)
 Figure 42. The Top 5 and 10 Largest Manufacturers of New Drug for Alzheimer's Treatment in the World: Market Share by New Drug for Alzheimer's Treatment Revenue in 2023
 Figure 43. Global New Drug for Alzheimer's Treatment Market Size Market Share by Region: 2019 VS 2023 VS 2030
 Figure 44. Global New Drug for Alzheimer's Treatment Sales in Volume Market Share by Region (2019-2030)
 Figure 45. Global New Drug for Alzheimer's Treatment Sales in Value Market Share by Region (2019-2030)
 Figure 46. Americas New Drug for Alzheimer's Treatment Sales in Volume Growth Rate 2019-2030 (K Dose)
 Figure 47. Americas New Drug for Alzheimer's Treatment Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 48. Americas New Drug for Alzheimer's Treatment Sales by Type (2019-2030) & (K Dose)
 Figure 49. Americas New Drug for Alzheimer's Treatment Sales Market Share in Volume by Type (2019-2030)
 Figure 50. Americas New Drug for Alzheimer's Treatment Sales by Application (2019-2030) & (K Dose)
 Figure 51. Americas New Drug for Alzheimer's Treatment Sales Market Share in Volume by Application (2019-2030)
 Figure 52. United States New Drug for Alzheimer's Treatment Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Canada New Drug for Alzheimer's Treatment Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Mexico New Drug for Alzheimer's Treatment Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Brazil New Drug for Alzheimer's Treatment Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 56. EMEA New Drug for Alzheimer's Treatment Sales in Volume Growth Rate 2019-2030 (K Dose)
 Figure 57. EMEA New Drug for Alzheimer's Treatment Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 58. EMEA New Drug for Alzheimer's Treatment Sales by Type (2019-2030) & (K Dose)
 Figure 59. EMEA New Drug for Alzheimer's Treatment Sales Market Share in Volume by Type (2019-2030)
 Figure 60. EMEA New Drug for Alzheimer's Treatment Sales by Application (2019-2030) & (K Dose)
 Figure 61. EMEA New Drug for Alzheimer's Treatment Sales Market Share in Volume by Application (2019-2030)
 Figure 62. Europe New Drug for Alzheimer's Treatment Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 63. Middle East New Drug for Alzheimer's Treatment Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 64. Africa New Drug for Alzheimer's Treatment Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 65. China New Drug for Alzheimer's Treatment Sales in Volume Growth Rate 2019-2030 (K Dose)
 Figure 66. China New Drug for Alzheimer's Treatment Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 67. China New Drug for Alzheimer's Treatment Sales by Type (2019-2030) & (K Dose)
 Figure 68. China New Drug for Alzheimer's Treatment Sales Market Share in Volume by Type (2019-2030)
 Figure 69. China New Drug for Alzheimer's Treatment Sales by Application (2019-2030) & (K Dose)
 Figure 70. China New Drug for Alzheimer's Treatment Sales Market Share in Volume by Application (2019-2030)
 Figure 71. APAC New Drug for Alzheimer's Treatment Sales in Volume Growth Rate 2019-2030 (K Dose)
 Figure 72. APAC New Drug for Alzheimer's Treatment Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 73. APAC New Drug for Alzheimer's Treatment Sales by Type (2019-2030) & (K Dose)
 Figure 74. APAC New Drug for Alzheimer's Treatment Sales Market Share in Volume by Type (2019-2030)
 Figure 75. APAC New Drug for Alzheimer's Treatment Sales by Application (2019-2030) & (K Dose)
 Figure 76. APAC New Drug for Alzheimer's Treatment Sales Market Share in Volume by Application (2019-2030)
 Figure 77. Japan New Drug for Alzheimer's Treatment Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 78. South Korea New Drug for Alzheimer's Treatment Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 79. China Taiwan New Drug for Alzheimer's Treatment Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 80. Southeast Asia New Drug for Alzheimer's Treatment Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 81. India New Drug for Alzheimer's Treatment Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 82. New Drug for Alzheimer's Treatment Value Chain
 Figure 83. New Drug for Alzheimer's Treatment Production Process
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed

Description

The global New Drug for Alzheimer's Treatment revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).

In United States the New Drug for Alzheimer's Treatment revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States New Drug for Alzheimer's Treatment market, also covers the segmentation data of other regions in regional level and county level.

The global key players of New Drug for Alzheimer's Treatment include Biogen, Eisai, Eli Lilly, Neurimmune, Roche, AstraZeneca, Green Valley, Vivoryon, Simcere, Johnson and Johnson, etc. The global five biggest players hold a share of % in 2023.

New Drug for Alzheimer's Treatment market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global New Drug for Alzheimer's Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the New Drug for Alzheimer's Treatment market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

Market Segmentation